RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells

Area of Science:

• Molecular Biology
• Virology
• Gene Therapy

Background:

• RNA interference (RNAi) is a mechanism for sequence-specific mRNA degradation induced by double-stranded RNA.
• RNAi has demonstrated efficacy in down-regulating gene expression and suppressing pathogen replication in mammalian cells.
• Hepatitis B virus (HBV) replication remains a significant therapeutic challenge.

Purpose of the Study:

• To evaluate the efficacy of vector-based small interfering RNA (siRNA) delivered by pSilencer2.0-U6 in inhibiting HBV replication.
• To assess the impact of RNAi on HBV gene expression at DNA, RNA, and protein levels.

Main Methods:

• Three HBV-targeting siRNA fragments (S, X, and C regions) were cloned into pSilencer vectors (pS, pX, pC).
• Expression plasmids were transfected into HepG2-N10 cells, a stable HBV-producing cell line.
• HBV replication markers (antigens, mRNA, DNA) were quantified using ELISA, RT-PCR, and quantitative real-time PCR.

Main Results:

• Vector-based RNAi significantly reduced hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) expression.
• RT-PCR confirmed effective degradation of viral mRNAs, reducing templates for protein synthesis and reverse transcription.
• Quantitative real-time PCR demonstrated efficient inhibition of HBV DNA replication.

Conclusions:

• RNA interference effectively inhibits HBV gene expression and replication in cell culture.
• Vector-based siRNA holds promise as a novel therapeutic strategy for treating HBV infection.